RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hugues Ouellet to Models, Molecular

This is a "connection" page, showing publications Hugues Ouellet has written about Models, Molecular.
Connection Strength

0.232
  1. Ouellet H, Johnston JB, Ortiz de Montellano PR. The Mycobacterium tuberculosis cytochrome P450 system. Arch Biochem Biophys. 2010 Jan 01; 493(1):82-95.
    View in: PubMed
    Score: 0.066
  2. Ouellet H, Juszczak L, Dantsker D, Samuni U, Ouellet YH, Savard PY, Wittenberg JB, Wittenberg BA, Friedman JM, Guertin M. Reactions of Mycobacterium tuberculosis truncated hemoglobin O with ligands reveal a novel ligand-inclusive hydrogen bond network. Biochemistry. 2003 May 20; 42(19):5764-74.
    View in: PubMed
    Score: 0.043
  3. Kells PM, Ouellet H, Santos-Aberturas J, Aparicio JF, Podust LM. Structure of cytochrome P450 PimD suggests epoxidation of the polyene macrolide pimaricin occurs via a hydroperoxoferric intermediate. Chem Biol. 2010 Aug 27; 17(8):841-51.
    View in: PubMed
    Score: 0.018
  4. Johnston JB, Ouellet H, Podust LM, Ortiz de Montellano PR. Structural control of cytochrome P450-catalyzed ?-hydroxylation. Arch Biochem Biophys. 2011 Mar 01; 507(1):86-94.
    View in: PubMed
    Score: 0.018
  5. Li S, Ouellet H, Sherman DH, Podust LM. Analysis of transient and catalytic desosamine-binding pockets in cytochrome P-450 PikC from Streptomyces venezuelae. J Biol Chem. 2009 Feb 27; 284(9):5723-30.
    View in: PubMed
    Score: 0.016
  6. Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Altek?ster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR. Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography. Antimicrob Agents Chemother. 2007 Nov; 51(11):3915-23.
    View in: PubMed
    Score: 0.014
  7. Milani M, Pesce A, Nardini M, Ouellet H, Ouellet Y, Dewilde S, Bocedi A, Ascenzi P, Guertin M, Moens L, Friedman JM, Wittenberg JB, Bolognesi M. Structural bases for heme binding and diatomic ligand recognition in truncated hemoglobins. J Inorg Biochem. 2005 Jan; 99(1):97-109.
    View in: PubMed
    Score: 0.012
  8. Dantsker D, Samuni U, Ouellet Y, Wittenberg BA, Wittenberg JB, Milani M, Bolognesi M, Guertin M, Friedman JM. Viscosity-dependent relaxation significantly modulates the kinetics of CO recombination in the truncated hemoglobin TrHbN from Mycobacterium tuberculosis. J Biol Chem. 2004 Sep 10; 279(37):38844-53.
    View in: PubMed
    Score: 0.012
  9. Milani M, Pesce A, Ouellet Y, Dewilde S, Friedman J, Ascenzi P, Guertin M, Bolognesi M. Heme-ligand tunneling in group I truncated hemoglobins. J Biol Chem. 2004 May 14; 279(20):21520-5.
    View in: PubMed
    Score: 0.011
  10. Milani M, Pesce A, Ouellet H, Guertin M, Bolognesi M. Truncated hemoglobins and nitric oxide action. IUBMB Life. 2003 Oct-Nov; 55(10-11):623-7.
    View in: PubMed
    Score: 0.011
  11. Milani M, Savard PY, Ouellet H, Ascenzi P, Guertin M, Bolognesi M. A TyrCD1/TrpG8 hydrogen bond network and a TyrB10TyrCD1 covalent link shape the heme distal site of Mycobacterium tuberculosis hemoglobin O. Proc Natl Acad Sci U S A. 2003 May 13; 100(10):5766-71.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support